🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty

RecruitingNAAges 50 Years - 80 YearsAllZagazig University
NCT05556759 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Approximately 1.66 million hip fractures happen in a year worldwide. About 95% of these fractures happen in individuals older than 60 years. Surgical treatment involving THA is considered the best option for patients with hip fractures and those with degenerative changes in the hip joint, especially in the elderly, however, it is associated with moderate to severe postoperative pain. Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility, and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesia techniques is of paramount importance. Moreover, early intervention of rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily. Effective pain management is one of the crucial components of enhanced recovery

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient acceptance. * Age 50-80 years old. * BMI ≤ 30 kg/m2 * ASA I - III. * Elective total hip arthroplasty under general anesthesia. Exclusion Criteria: * History of allergy to the LA agents used in this study * Skin lesion at the needle insertion site, * Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders * Pre-existing neurological deficit in the lower extremity * History of chronic pain and taking analgesics * History of cognitive dysfunction or mental illness
💊

What it tests

  • control
  • IPS
  • Supra-iliac QL
📍

Where

1 site
Faculty of medicine, zagazig university
Zagazig, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy